{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:17:30Z","timestamp":1788866250111,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["RM1GM131968"],"award-info":[{"award-number":["RM1GM131968"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013678","name":"University of Colorado Cancer Center","doi-asserted-by":"crossref","award":["P30CA046934"],"award-info":[{"award-number":["P30CA046934"]}],"id":[{"id":"10.13039\/100013678","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03123-0","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T10:00:10Z","timestamp":1750586410000},"page":"866-881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Proteomics of arterial thrombi in acute limb ischemia"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3697-9175","authenticated-orcid":false,"given":"Robert D.","family":"Stegman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-9338","authenticated-orcid":false,"given":"Lauren R.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-838X","authenticated-orcid":false,"given":"Kirk C.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0254-4936","authenticated-orcid":false,"given":"Adrianna","family":"Kayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahana","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9890-8639","authenticated-orcid":false,"given":"Ara","family":"Metjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-5494","authenticated-orcid":false,"given":"Max V.","family":"Wohlauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,22]]},"reference":[{"issue":"4","key":"3123_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3400\/avd.ra.18-00074","volume":"11","author":"H Obara","year":"2018","unstructured":"Obara H, Matsubara K, Kitagawa Y (2018) Acute limb ischemia. Ann Vasc Dis 11(4):443\u2013448. https:\/\/doi.org\/10.3400\/avd.ra.18-00074","journal-title":"Ann Vasc Dis"},{"issue":"19","key":"3123_CR2","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.115.016424","volume":"132","author":"DP Howard","year":"2015","unstructured":"Howard DP, Banerjee A, Fairhead JF et al (2015) Population-based study of incidence, risk factors, outcome, and prognosis of ischemic peripheral arterial events: implications for prevention. Circulation 132(19):1805\u20131815. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016424","journal-title":"Circulation"},{"key":"3123_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.avsg.2015.10.001","volume":"30","author":"EA Genovese","year":"2016","unstructured":"Genovese EA, Chaer RA, Taha AG et al (2016) Risk factors for long-term mortality and amputation after open and endovascular treatment of acute limb ischemia. Ann Vasc Surg 30:82\u201392. https:\/\/doi.org\/10.1016\/j.avsg.2015.10.001","journal-title":"Ann Vasc Surg"},{"issue":"13","key":"3123_CR4","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1161\/01.cir.103.13.1718","volume":"103","author":"P Libby","year":"2001","unstructured":"Libby P, Simon DI (2001) Inflammation and thrombosis: the clot thickens. Circulation 103(13):1718\u20131720. https:\/\/doi.org\/10.1161\/01.cir.103.13.1718","journal-title":"Circulation"},{"key":"3123_CR5","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","volume":"293","author":"RP Rother","year":"2005","unstructured":"Rother RP, Bell L, Hillmen P et al (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293:1653\u20131662. https:\/\/doi.org\/10.1001\/jama.293.13.1653","journal-title":"JAMA"},{"key":"3123_CR6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-134-sci-40","author":"W Ruf","year":"2019","unstructured":"Ruf W (2019) Links between complement activation and thrombosis. Blood. https:\/\/doi.org\/10.1182\/blood-2019-134-sci-40","journal-title":"Blood"},{"issue":"1","key":"3123_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","volume":"29","author":"JC Chapin","year":"2015","unstructured":"Chapin JC, Hajjar KA (2015) Fibrinolysis and the control of blood coagulation. Blood Rev 29(1):17\u201324. https:\/\/doi.org\/10.1016\/j.blre.2014.09.003","journal-title":"Blood Rev"},{"issue":"9","key":"3123_CR8","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1161\/STROKEAHA.120.032129","volume":"52","author":"L Suissa","year":"2021","unstructured":"Suissa L, Guigonis JM, Graslin F et al (2021) Combined omic analyzes of cerebral thrombi: a new molecular approach to identify cardioembolic stroke origin. Stroke 52(9):2892\u20132901. https:\/\/doi.org\/10.1161\/STROKEAHA.120.032129","journal-title":"Stroke"},{"issue":"6","key":"3123_CR9","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1039\/c1mb05055a","volume":"7","author":"PH Hung","year":"2011","unstructured":"Hung PH, Chen YW, Cheng KC et al (2011) Plasma proteomic analysis of the critical limb ischemia markers in diabetic patients with hemodialysis. Mol Biosyst 7(6):1990\u20131998. https:\/\/doi.org\/10.1039\/c1mb05055a","journal-title":"Mol Biosyst"},{"key":"3123_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.thromres.2020.01.008","volume":"187","author":"IA Karpi\u0144ska","year":"2020","unstructured":"Karpi\u0144ska IA, Nowakowski T, Wypasek E et al (2020) A prothrombotic state and denser clot formation in patients following acute limb ischemia of unknown cause. Thromb Res 187:32\u201338. https:\/\/doi.org\/10.1016\/j.thromres.2020.01.008","journal-title":"Thromb Res"},{"key":"3123_CR11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.AC119.007981","author":"LR Schmitt","year":"2019","unstructured":"Schmitt LR, Henderson R, Barrett A et al (2019) Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.AC119.007981","journal-title":"J Biol Chem"},{"issue":"9","key":"3123_CR12","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.1074\/jbc.M109677200","volume":"277","author":"TJ Podor","year":"2002","unstructured":"Podor TJ, Campbell S, Chindemi P et al (2002) Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A\/gamma\u2019 fibrinogen. J Biol Chem 277(9):7520\u20137528. https:\/\/doi.org\/10.1074\/jbc.M109677200","journal-title":"J Biol Chem"},{"issue":"3","key":"3123_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1213\/ANE.0000000000004234","volume":"129","author":"HB Moore","year":"2019","unstructured":"Moore HB, Moore EE, Neal MD et al (2019) Fibrinolysis shutdown in trauma: historical review and clinical implications. Anesth Analg 129(3):762\u2013773. https:\/\/doi.org\/10.1213\/ANE.0000000000004234","journal-title":"Anesth Analg"},{"issue":"16","key":"3123_CR14","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2174\/1389450120666190715102510","volume":"20","author":"T Urano","year":"2019","unstructured":"Urano T, Suzuki Y, Iwaki T et al (2019) Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis. Curr Drug Targets 20(16):1695\u20131701","journal-title":"Curr Drug Targets"},{"issue":"4","key":"3123_CR15","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1182\/blood-2003-12-4293","volume":"104","author":"YP Wu","year":"2004","unstructured":"Wu YP, Bloemendal HJ, Voest EE et al (2004) Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin. Blood 104(4):1034\u20131041. https:\/\/doi.org\/10.1182\/blood-2003-12-4293","journal-title":"Blood"},{"issue":"31","key":"3123_CR16","doi-asserted-by":"publisher","first-page":"19836","DOI":"10.1016\/S0021-9258(17)32096-3","volume":"269","author":"D Seiffert","year":"1994","unstructured":"Seiffert D, Crain K, Wagner NV et al (1994) Vitronectin gene expression in vivo: evidence for extrahepatic synthesis and acute phase regulation. J Biol Chem 269(31):19836\u201319842. https:\/\/doi.org\/10.1016\/S0021-9258(17)32096-3","journal-title":"J Biol Chem"},{"issue":"4","key":"3123_CR17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/s0008-6363(01)00547-8","volume":"53","author":"P Dufourcq","year":"2002","unstructured":"Dufourcq P, Couffinhal T, Alzieu P et al (2002) Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation. Cardiovasc Res 53(4):952\u2013962. https:\/\/doi.org\/10.1016\/s0008-6363(01)00547-8","journal-title":"Cardiovasc Res"},{"issue":"12","key":"3123_CR18","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1111\/jth.13869","volume":"15","author":"M Luo","year":"2017","unstructured":"Luo M, Ji Y, Luo Y et al (2017) Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin. J Thromb Haemost 15(12):2451\u20132460. https:\/\/doi.org\/10.1111\/jth.13869","journal-title":"J Thromb Haemost"},{"issue":"7","key":"3123_CR19","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1182\/blood-2010-09-303842","volume":"117","author":"IK Poon","year":"2011","unstructured":"Poon IK, Patel KK, Davis DS, Parish CR, Hulett MD (2011) Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood 117(7):2093\u20132101. https:\/\/doi.org\/10.1182\/blood-2010-09-303842","journal-title":"Blood"},{"issue":"35","key":"3123_CR20","doi-asserted-by":"publisher","first-page":"30314","DOI":"10.1074\/jbc.M111.253831","volume":"286","author":"TT Vu","year":"2011","unstructured":"Vu TT, Stafford AR, Leslie BA et al (2011) Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma\u2019-chain. J Biol Chem 286(35):30314\u201330323. https:\/\/doi.org\/10.1074\/jbc.M111.253831","journal-title":"J Biol Chem"},{"issue":"5","key":"3123_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1538-7836.2005.01238.x","volume":"3","author":"N Tsuchida-Straeten","year":"2005","unstructured":"Tsuchida-Straeten N, Ensslen S, Sch\u00e4fer C et al (2005) Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J Thromb Haemost 3(5):865\u2013872. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01238.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3123_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1538-7836.2010.04070.x","volume":"9","author":"I Kom\u00e1romi","year":"2011","unstructured":"Kom\u00e1romi I, Bagoly Z, Muszbek L (2011) Factor XIII: novel structural and functional aspects. J Thromb Haemost 9(1):9\u201320. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04070.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3123_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.thromres.2007.02.010","volume":"121","author":"S Gando","year":"2007","unstructured":"Gando S, Hayakawa M, Sawamura A et al (2007) The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation. Thromb Res 121(1):67\u201373. https:\/\/doi.org\/10.1016\/j.thromres.2007.02.010","journal-title":"Thromb Res"},{"key":"3123_CR24","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1084\/jem.166.6.1836","volume":"166","author":"JI Weitz","year":"1987","unstructured":"Weitz JI, Huang AJ, Landman SL et al (1987) Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinases. J Exp Med 166:1836\u20131850. https:\/\/doi.org\/10.1084\/jem.166.6.1836","journal-title":"J Exp Med"},{"key":"3123_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/B978-012369367-9\/50783-7","volume-title":"Platelets","author":"BA Maron","year":"2007","unstructured":"Maron BA, Loscalzo J (2007) The role of platelets in fibrinolysis. In: Michelson AD (ed) Platelets, 2nd edn. Academic Press, pp 415\u2013430. ISBN: 9780123693679","edition":"2"},{"key":"3123_CR26","unstructured":"Katz JM, Tadi P (2023) Physiology, plasminogen activation [Updated 26 Sep 2022]. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL"},{"issue":"2","key":"3123_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1172\/JCI109671.PMID:6444305;PMCID:PMC371366","volume":"65","author":"Y Sakata","year":"1980","unstructured":"Sakata Y, Aoki N (1980) Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Investig 65(2):290\u2013297. https:\/\/doi.org\/10.1172\/JCI109671.PMID:6444305;PMCID:PMC371366","journal-title":"J Clin Investig"},{"key":"3123_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/156795","volume":"2012","author":"A D\u00edaz-Ramos","year":"2012","unstructured":"D\u00edaz-Ramos A, Roig-Borrellas A, Garc\u00eda-Melero A et al (2012) \u03b1-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol 2012:156795. https:\/\/doi.org\/10.1155\/2012\/156795","journal-title":"J Biomed Biotechnol"},{"issue":"1\u20132","key":"3123_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1432-1033.1995.tb20403.x","volume":"227","author":"A Redlitz","year":"1995","unstructured":"Redlitz A, Fowler BJ, Plow EF et al (1995) The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 227(1\u20132):407\u2013415. https:\/\/doi.org\/10.1111\/j.1432-1033.1995.tb20403.x","journal-title":"Eur J Biochem"},{"issue":"17","key":"3123_CR30","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","volume":"131","author":"C Maas","year":"2018","unstructured":"Maas C, Renn\u00e9 T (2018) Coagulation factor XII in thrombosis and inflammation. Blood 131(17):1903\u20131909. https:\/\/doi.org\/10.1182\/blood-2017-04-569111","journal-title":"Blood"},{"issue":"2","key":"3123_CR31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.thromres.2015.06.028","volume":"136","author":"J Konings","year":"2015","unstructured":"Konings J, Hoving LR, Ari\u00ebns RS et al (2015) The role of activated coagulation factor XII in overall clot stability and fibrinolysis. Thromb Res 136(2):474\u2013480. https:\/\/doi.org\/10.1016\/j.thromres.2015.06.028","journal-title":"Thromb Res"},{"issue":"2","key":"3123_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.20050664","volume":"202","author":"T Renn\u00e9","year":"2005","unstructured":"Renn\u00e9 T, Pozgajov\u00e1 M, Gr\u00fcner S et al (2005) Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 202(2):271\u2013281. https:\/\/doi.org\/10.1084\/jem.20050664","journal-title":"J Exp Med"},{"issue":"3","key":"3123_CR33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","volume":"125","author":"E Stavrou","year":"2010","unstructured":"Stavrou E, Schmaier AH (2010) Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. Thromb Res 125(3):210\u2013215. https:\/\/doi.org\/10.1016\/j.thromres.2009.11.028","journal-title":"Thromb Res"},{"issue":"7","key":"3123_CR34","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1055\/s-0039-1687875","volume":"119","author":"KN Mouapi","year":"2019","unstructured":"Mouapi KN, Wagner LJ, Stephens CA et al (2019) Evaluating the effects of fibrinogen \u03b1C mutations on the ability of factor XIII to crosslink the reactive \u03b1C glutamines (Q237, Q328, Q366). Thromb Haemost 119(7):1048\u20131057. https:\/\/doi.org\/10.1055\/s-0039-1687875","journal-title":"Thromb Haemost"},{"issue":"2","key":"3123_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0005-2744(81)90016-4","volume":"661","author":"T Tamaki","year":"1981","unstructured":"Tamaki T, Aoki N (1981) Cross-linking of alpha 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochim Biophys Acta 661(2):280\u2013286","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"3123_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/jcm10030427","volume":"10","author":"MT Hopp","year":"2021","unstructured":"Hopp MT, Imhof D (2021) Linking labile heme with thrombosis. J Clin Med 10(3):427. https:\/\/doi.org\/10.3390\/jcm10030427","journal-title":"J Clin Med"},{"key":"3123_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3324\/haematol.2014.114728","volume":"100","author":"EM Sparkenbaugh","year":"2015","unstructured":"Sparkenbaugh EM, Chantrathammachart P, Wang S et al (2015) Excess of heme induces tissue factor-dependent activation of coagulation in mice. Haematologica 100:308\u2013314. https:\/\/doi.org\/10.3324\/haematol.2014.114728","journal-title":"Haematologica"},{"key":"3123_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/blood-2013-03-489245","volume":"122","author":"M Frimat","year":"2013","unstructured":"Frimat M, Tabarin F, Dimitrov JD et al (2013) Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome. Blood 122:282\u2013292. https:\/\/doi.org\/10.1182\/blood-2013-03-489245","journal-title":"Blood"},{"issue":"3","key":"3123_CR39","doi-asserted-by":"publisher","first-page":"H671","DOI":"10.1152\/ajpheart.00280.2019","volume":"318","author":"KA Nath","year":"2020","unstructured":"Nath KA, Grande JP, Belcher JD et al (2020) Antithrombotic effects of heme-degrading and heme-binding proteins. Am J Physiol Heart Circ Physiol 318(3):H671\u2013H681. https:\/\/doi.org\/10.1152\/ajpheart.00280.2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"3123_CR40","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/STROKEAHA.123.040205","volume":"54","author":"I Galea","year":"2023","unstructured":"Galea I, Bandyopadhyay S, Bulters D, SAH Delphi Group et al (2023) Haptoglobin treatment for aneurysmal subarachnoid hemorrhage: review and expert consensus on clinical translation. Stroke 54(7):1930\u20131942. https:\/\/doi.org\/10.1161\/STROKEAHA.123.040205","journal-title":"Stroke"},{"issue":"1","key":"3123_CR41","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1038\/s41598-020-59526-x","volume":"10","author":"IN Chernysh","year":"2020","unstructured":"Chernysh IN, Nagaswami C, Kosolapova S et al (2020) The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli. Sci Rep 10(1):5112. https:\/\/doi.org\/10.1038\/s41598-020-59526-x","journal-title":"Sci Rep"},{"issue":"3","key":"3123_CR42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.150.3.633","volume":"150","author":"MJ Polley","year":"1979","unstructured":"Polley MJ, Nachman RL (1979) Human complement in thrombin-mediated platelet function: uptake of the C5b\u20139 complex. J Exp Med 150(3):633\u2013645. https:\/\/doi.org\/10.1084\/jem.150.3.633","journal-title":"J Exp Med"},{"issue":"34","key":"3123_CR43","doi-asserted-by":"publisher","first-page":"18205","DOI":"10.1016\/S0021-9258(19)81346-7","volume":"263","author":"PJ Sims","year":"1988","unstructured":"Sims PJ, Faioni EM, Wiedmer T et al (1988) Complement proteins C5b\u20139 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263(34):18205\u201318212. https:\/\/doi.org\/10.1016\/S0021-9258(19)81346-7","journal-title":"J Biol Chem"},{"issue":"7","key":"3123_CR44","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","volume":"177","author":"K Ritis","year":"2006","unstructured":"Ritis K, Doumas M, Mastellos D et al (2006) A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 177(7):4794\u20134802. https:\/\/doi.org\/10.4049\/jimmunol.177.7.4794","journal-title":"J Immunol"},{"issue":"4","key":"3123_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1055\/s-0031-1276584","volume":"37","author":"B Dahlb\u00e4ck","year":"2011","unstructured":"Dahlb\u00e4ck B (2011) C4b-binding protein: a forgotten factor in thrombosis and hemostasis. Semin Thromb Hemost 37(4):355\u2013361. https:\/\/doi.org\/10.1055\/s-0031-1276584","journal-title":"Semin Thromb Hemost"},{"key":"3123_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molimm.2017.01.015","volume":"84","author":"J Ferluga","year":"2017","unstructured":"Ferluga J, Kouser L, Murugaiah V et al (2017) Potential influences of complement factor H in autoimmune inflammatory and thrombotic disorders. Mol Immunol 84:84\u2013106. https:\/\/doi.org\/10.1016\/j.molimm.2017.01.015","journal-title":"Mol Immunol"},{"key":"3123_CR47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.molimm.2014.02.012","volume":"59","author":"J Ferluga","year":"2014","unstructured":"Ferluga J, Kishore U, Sim RB (2014) A potential anti-coagulant role of complement factor H. Mol Immunol 59:188\u2013193. https:\/\/doi.org\/10.1016\/j.molimm.2014.02.012","journal-title":"Mol Immunol"},{"issue":"8","key":"3123_CR48","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00125-014-3267-z","volume":"57","author":"K Hess","year":"2014","unstructured":"Hess K, Alzahrani SH, Price JF et al (2014) Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3. Diabetologia 57(8):1737\u20131741. https:\/\/doi.org\/10.1007\/s00125-014-3267-z","journal-title":"Diabetologia"},{"issue":"5","key":"3123_CR49","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1538-7836.2009.03334.x","volume":"7","author":"FC Gushiken","year":"2009","unstructured":"Gushiken FC, Han H, Li J et al (2009) Abnormal platelet function in C3-deficient mice. J Thromb Haemost 7(5):865\u2013870. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03334.x","journal-title":"J Thromb Haemost"},{"key":"3123_CR50","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.4049\/jimmunol.1501876","volume":"197","author":"R K\u00f6lm","year":"2016","unstructured":"K\u00f6lm R, Schaller M, Roumenina LT et al (2016) Von willebrand factor interacts with surface-bound C1q and induces platelet rolling. J Immunol 197:3669\u20133679. https:\/\/doi.org\/10.4049\/jimmunol.1501876","journal-title":"J Immunol"},{"key":"3123_CR51","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3389\/fimmu.2020.01522","volume":"11","author":"C Donat","year":"2020","unstructured":"Donat C, K\u00f6lm R, Csorba K et al (2020) Complement C1q enhances primary hemostasis. Front Immunol 11:1522. https:\/\/doi.org\/10.3389\/fimmu.2020.01522","journal-title":"Front Immunol"},{"issue":"16","key":"3123_CR52","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/eurheartj\/ehu356","volume":"36","author":"I Ramaiola","year":"2015","unstructured":"Ramaiola I, Padr\u00f3 T, Pe\u00f1a E et al (2015) Changes in thrombus composition and profilin-1 release in acute myocardial infarction. Eur Heart J 36(16):965\u2013975. https:\/\/doi.org\/10.1093\/eurheartj\/ehu356","journal-title":"Eur Heart J"},{"issue":"12","key":"3123_CR53","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1111\/jth.15035","volume":"18","author":"ME Quach","year":"2020","unstructured":"Quach ME, Li R (2020) Structure-function of platelet glycoprotein Ib-IX. J Thromb Haemost 18(12):3131\u20133141","journal-title":"J Thromb Haemost"},{"issue":"6","key":"3123_CR54","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.bpj.2013.07.046","volume":"105","author":"M Mehrbod","year":"2013","unstructured":"Mehrbod M, Trisno S, Mofrad MR (2013) On the activation of integrin \u03b1IIb\u03b23: outside-in and inside-out pathways. Biophys J 105(6):1304\u20131315. https:\/\/doi.org\/10.1016\/j.bpj.2013.07.046","journal-title":"Biophys J"},{"key":"3123_CR55","doi-asserted-by":"publisher","first-page":"16900","DOI":"10.1073\/pnas.0606605103","volume":"103","author":"W Bergmeier","year":"2006","unstructured":"Bergmeier W, Piffath CL, Goerge T et al (2006) The role of platelet adhesion receptor GPIb\u03b1 far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci USA 103:16900\u201316905. https:\/\/doi.org\/10.1073\/pnas.0606605103","journal-title":"Proc Natl Acad Sci USA"},{"key":"3123_CR56","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1182\/blood-2005-02-0618","volume":"107","author":"AJ Reininger","year":"2006","unstructured":"Reininger AJ, Heijnen HF, Schumann H et al (2006) Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 107:3537\u20133545. https:\/\/doi.org\/10.1182\/blood-2005-02-0618","journal-title":"Blood"},{"key":"3123_CR57","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1182\/blood-2005-05-1933","volume":"106","author":"A Garcia","year":"2005","unstructured":"Garcia A, Quinton TM, Dorsam RT et al (2005) Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF\/GPIb-induced fibrinogen receptor activation in human platelets. Blood 106:3410\u20133414. https:\/\/doi.org\/10.1182\/blood-2005-05-1933","journal-title":"Blood"},{"key":"3123_CR58","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1182\/blood-2005-04-1667","volume":"106","author":"J Liu","year":"2005","unstructured":"Liu J, Pestina TI, Berndt MC et al (2005) Botrocetin\/VWF-induced signaling through GPIb-IX-V produces TxA2 in an alphaIIbbeta3- and aggregation-independent manner. Blood 106:2750\u20132756. https:\/\/doi.org\/10.1182\/blood-2005-04-1667","journal-title":"Blood"},{"issue":"29","key":"3123_CR59","doi-asserted-by":"publisher","first-page":"21785","DOI":"10.1074\/jbc.R000003200","volume":"275","author":"EF Plow","year":"2000","unstructured":"Plow EF, Haas TA, Zhang L et al (2000) Ligand binding to integrins. J Biol Chem 275(29):21785\u201321788. https:\/\/doi.org\/10.1074\/jbc.R000003200","journal-title":"J Biol Chem"},{"issue":"5","key":"3123_CR60","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/jcbfm.2009.272","volume":"30","author":"Y Izuhara","year":"2010","unstructured":"Izuhara Y, Yamaoka N, Kodama H et al (2010) A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates. J Cereb Blood Flow Metab 30(5):904\u2013912. https:\/\/doi.org\/10.1038\/jcbfm.2009.272","journal-title":"J Cereb Blood Flow Metab"},{"key":"3123_CR61","doi-asserted-by":"publisher","unstructured":"Hillmen P, Szer J, Weitz I et al (2021) Pegcetacoplan versus eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 384:1028\u20131037. https:\/\/doi.org\/10.1056\/NEJMoa2029073 [Erratum in: N Engl J Med 2024;390:1060. https:\/\/doi.org\/10.1056\/NEJMx240003]","DOI":"10.1056\/NEJMoa2029073"},{"key":"3123_CR62","doi-asserted-by":"publisher","first-page":"601","DOI":"10.15585\/mmwr.mm7222a3","volume":"72","author":"JM Jones","year":"2023","unstructured":"Jones JM, Manrique IM, Stone MS et al (2023) Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status \u2014 United States, April 2021\u2013September 2022. MMWR Morb Mortal Wkly Rep 72:601\u2013605. https:\/\/doi.org\/10.15585\/mmwr.mm7222a3","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03123-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03123-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03123-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:28:07Z","timestamp":1762939687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03123-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,22]]},"references-count":62,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3123"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03123-0","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,22]]},"assertion":[{"value":"26 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing or financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Human blood and thrombus were collected in accordance with the Declaration of Helsinki. Informed consent was obtained from all patients who provided samples collected under the Colorado Multiple Institutional Review Board protocols 19-2998 and 17-1286.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}